What it does
Key investments include Kirkstall, UV light detection group Paraytec, propeller and rotating shaft monitoring group Gyrometric Systems, microscope imaging firm PhaseFocus and Sentinel Medical, a spin-out of Paraytec developing technology to detect cancer cells in urine.
The company also has a 51.72% stake in Pharm2Farm Limited (P2F), a plant nutrients specialist.
How it's doing
The most recent portfolio update reported that 100% owned Paraytec Limited, in partnership with the University of Sheffield, had completed the first four stages of a five-stage process to produce an artificial version of the coronavirus in order to avoid using live versions of the disease during proof-of-concept development of the test,
The final construction stages of the viral mimic will be reported on in the next phase.
In July, Braveheart also took a stake in Remote Montioresd Sytems, which it subsequently increased to 25.8% through a subscription in a fundraise by RMS in July.
Two funding rounds in 2020 have raised £625,000 for Braveheart.
- New round of user trials for Paraytec
- Commercial orders for Gyrometric
- Just taken a stake in Remote Monitored Systems